08.01.05 |
Restricted Use
|
 |
Brentuximab vedotin Adcetris® |
08.01.05 |
Restricted Use
|
 |
Inotuzumab Ozogamicin Besponsa® |
08.01.02 |
Restricted Use
|
 |
Liposomal Cytarabine-Daunorubicin Vyxeos® |
08.01.02 |
Restricted Use
|
 |
Pegylated-liposomal doxorubicin Caelyx® |
08.02.04 |
Formulary
|
 |
Tisagenlecleucel Kymriah® |